LIM kinase inhibitors target LIM kinases, a family of enzymes involved in the regulation of the actin cytoskeleton and cell cycle progression. LIM kinases phosphorylate and inactivate cofilin, a protein that disassembles actin filaments, thus controlling cell shape, motility, and division. Inhibiting LIM kinases can affect these processes, leading to altered cell cycle dynamics and potential apoptosis. LIM kinase inhibitors are important tools in cancer research and the study of cell motility and invasion. At CymitQuimica, we provide a selection of high-quality LIM kinase inhibitors to support your research in cell signaling, cytoskeletal dynamics, and oncology.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.